Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $27.5000 (11.34%) ($26.1100 - $31.9000) on Mon. Nov. 13, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.74% (three month average) | RSI | 64 | Latest Price | $27.5000(11.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 5.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.87% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-8%) SLV(-6%) SIL(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.87% (StdDev 11.74%) | Hourly BBV | 0 () | Intraday Trend | 3.8% | | | |
|
5 Day Moving Average | $23.5(17.02%) | 10 Day Moving Average | $23.2(18.53%) | 20 Day Moving Average | $23.38(17.62%) | To recent high | -20.3% | To recent low | 183.5% | Market Cap | $542m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |